GentiBio
Total Awards:
1
Award Value:
$7,766,382
Institution type:
For profit
Short Name:
GentiBio
Awards to the Institution
| Program Type | Investigator | Grant Title | Award Value |
|---|---|---|---|
| Clinical Trial Stage Projects | Mark Bach | A Phase 1 study of an engineered Treg cell therapy, GNTI-122, in adults with recently diagnosed Type 1 Diabetes | $7,766,382 |
| Total: $7,766,382.00 |